Skip to main content
SpringerLink
Log in

Management of Side Effects of Therapy

  • Chapter
  • First Online:
Prostate Cancer Survivorship

  • 41 Accesses

Abstract

By 2030, prostate cancer is estimated to be the most common cancer overall [1]. Intermittent androgen deprivation is increasingly being employed as an alternative to continuous lifelong androgen deprivation therapy for men with advanced or recurrent prostate cancer [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Aarts MJ, Mols F, Thong MS, Louwman MW, Coebergh JW, van de Poll-Franse LV. Long-term prostate cancer survivors with low socioeconomic status reported worse mental health-related quality of life in a population-based study. Urology. 2010;76:1224–30.

    Article  Google Scholar 

  2. Akbal C, Tinay I, Simsek F, Turkeri LN. Erectile dysfunction following radiotherapy and brachytherapy for prostate cancer: pathophysiology, prevention and treatment. Int Urol Nephrol. 2008;40:355–63.

    Article  Google Scholar 

  3. Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvière O, Schoots IG, Wiegel T, Cornford P. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol. 2017;71(4):618–29.

    Article  Google Scholar 

  4. Albersen M, Orabi H, Lue TF. Evaluation and treatment of erectile dysfunction in the aging male: a mini-review. Gerontology. 2012;58:3–14.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Royal Free Hospital and UCL, London, United Kingdom

    Sanchia S. Goonewardene

  2. North Bristol NHS Trust, Bristol, United Kingdom

    Raj Persad

Authors
  1. Sanchia S. Goonewardene
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raj Persad
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Goonewardene, S.S., Persad, R. (2018). Management of Side Effects of Therapy. In: Prostate Cancer Survivorship . Springer, Cham. https://doi.org/10.1007/978-3-319-65358-7_112

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-65358-7_112

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-65357-0

  • Online ISBN: 978-3-319-65358-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation